EP3908321
Lyfjasamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.1.2020EP published:
15.11.2023EP application number:
20700453.2
EP translation filed:
3.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
7.1.2040Expiry date:
7.1.2027Next due date:
31.1.2027
Title in English:
PHARMACEUTICAL COMPOSITIONLanguage of the patent:
English
Timeline
Today
8.1.2020EP application
15.11.2023EP Publication
3.1.2024Translation submitted
15.2.2024Registration published
7.1.2027Expires
Owner
Name:
MEDINCELL S.A.Address:
3 Rue des Frères Lumière, 34830 Jacou, FR
Inventor
Name:
ROBERGE, ChristopheAddress:
34830 Jacou, FR
Name:
LOPEZ NORIEGA, AdolfoAddress:
34830 Jacou, FR
Name:
CROS, Jean ManuelAddress:
34830 Jacou, FR
Name:
SERINDOUX, JulietteAddress:
34830 Jacou, FR
Name:
OSTER, MurielleAddress:
34830 Jacou, FR
Name:
LIU, FangAddress:
34830 Jacou, FR
Name:
MOLINIER, CharlotteAddress:
34830 Jacou, FR
Name:
GRIZOT, SylvestreAddress:
34830 Jacou, FR
Name:
VRLINIC, TjasaAddress:
34830 Jacou, FR
Name:
NG, FeifeiAddress:
34830 Jacou, FR
Name:
GUÉGAIN, EliseAddress:
34830 Jacou, FR
Name:
CAGNON, Marie-EmérentienneAddress:
34830 Jacou, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201900258Date:
8.1.2019Country:
GB
Classification
Categories:
A61K 47/34, A61K 9/00, A61K 31/445
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 24.1.2024
Expires: 7.1.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 29.1.2025
Expires: 7.1.2026
Payer: Árnason Faktor ehf.
Number: 7
Paid: 28.1.2026
Expires: 7.1.2027
Payer: Árnason Faktor ehf.